Returns and Disposal of Cannabis Prescriptions in UK Pharmacies

Why Patient Returns of Cannabis Are Common

• Patients frequently return unused cannabis when they discontinue treatment, switch products, or experience adverse effects
• Product quality concerns — visible mould, unexpected appearance, off-taste — prompt return before full dispensing of the product
• Prescriber discontinuation (e.g., due to adverse event or therapeutic failure) leaves patients with unused product
• Patients who are hospitalised or incapacitated may have their carers return unused cannabis on their behalf

Unlike many medications, cannabis is frequently returned to pharmacies for a variety of reasons that reflect the individualised and often iterative nature of medical cannabis treatment. Pharmacies must have a clear, consistent policy for accepting and handling returned cannabis that complies with controlled drug legislation and protects both the patient and the pharmacy from risk.

Legal Basis for Accepting Cannabis Returns

• Pharmacies may accept returned Schedule 2 drugs from patients under the Misuse of Drugs Regulations 2001
• Returned cannabis must be recorded in the controlled drug register: date, quantity received, patient name, and disposal method
• Returned product cannot be re-dispensed to another patient under any circumstances
• The return must be handled by a trained controlled drug handler and logged on the same day as receipt

The legal framework for accepting controlled drug returns is clear, but the practical management of returns requires specific training and robust procedures. Pharmacies that have not trained their staff on cannabis returns risk regulatory non-compliance and, in the event of an inspection, may face enforcement action. Incorporating cannabis return management into staff induction programmes is a straightforward way to ensure consistent compliance.

Disposal Methods for Returned and Expired Cannabis

• Liquid preparations (oils): transfer to a sealed, denaturing container using a pharmaceutical denaturing agent before collection by waste contractor
• Dried flower: place in a denaturing pouch or container; do not attempt to destroy in-house
• Vape cartridges: separate the cannabinoid-containing component from the hardware before disposal
• Waste collected by a licensed clinical waste contractor with specific authorisation for controlled drug waste

Home disposal of cannabis — whether by the patient or by untrained pharmacy staff — is illegal for Schedule 2 preparations. The requirement to use a licensed controlled drug waste contractor adds cost and logistical complexity to cannabis dispensing operations, but it is non-negotiable. Pharmacies should include waste disposal costs in their cannabis service pricing model and maintain current contracts with compliant waste contractors.

Record-Keeping for Returns and Waste Disposals

• Controlled drug register: separate section for returns and disposals, distinct from main stock record
• Waste disposal receipt: retain a copy of every waste collection docket for two years minimum
• CCTV: recording of the disposal process provides additional audit trail protection
• Reporting to the Accountable Officer: any discrepancy between recorded returns and waste disposal quantities must be reported promptly

The audit trail for cannabis returns and disposals must be as rigorous as for initial dispensing. Inspectors from the Home Office and the CQC will examine the controlled drug register for consistency, cross-referencing receipt entries with disposal records and physical stock counts. A clear, complete, and accurate record demonstrates professional management and significantly reduces the risk of enforcement action following an inspection.